Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03915925 · ClinicalTrials.gov registry record
Short-term Clinical Deterioration After Acute Pulmonary Embolism
A clinical trial of Pulmonary Embolism, sponsored by Wake Forest University Health Sciences.
- Completed
- Registry status
- 935
- Enrollment target
- 6
- Study locations
NCT03915925 is a study of Pulmonary Embolism that has completed, run by Wake Forest University Health Sciences. The registered enrollment target is 935 participants, below the 3,039-participant average among 48 other Pulmonary Embolism trials with a reported enrollment target (69% lower). The trial reports 6 study locations across 6 states.
The verdict
NCT03915925, a study of Pulmonary Embolism, has completed, sponsored by Wake Forest University Health Sciences.
- COMPLETED
- Registry status
- 935 participants
- Enrollment target
- 6
- Study locations
Study Summary
This is a prospective, observational, multicenter cohort study to compare right ventricular dysfunction dependent and independent prognostic models for short-term serous adverse events in patients who are diagnosed with pulmonary embolism in the emergency department. Clinical endpoints are assessed at days 1-5. A thirty-day follow-up phone call is conducted to obtain further clinical endpoints and a quality of life assessment.
Conditions Studied
Study Locations (6)
California
- San Diego Medical Center - San Diego
Delaware
- Christiana Care Health System - Newark
Florida
- Orlando Regional Medical Center - Orlando
North Carolina
- Carolinas Medical Center - Main - Charlotte
Tennessee
- Vanderbilt Medical Center - Nashville
Utah
- Univeristy of Utah Hospital - Salt Lake City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 935 participants |
| Start Date | 2018-09-30 |
| Est. Completion | 2020-11-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03915925
The ClinicalTrials.gov registry entry for NCT03915925 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 935 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,039-participant average among 48 other Pulmonary Embolism trials with a reported enrollment target (69% lower). The listed sponsor is Wake Forest University Health Sciences, which has 1,140 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Pulmonary Embolism appearing as the primary indexed condition, and to 0 interventions.
NCT03915925 reports 6 study locations spanning 6 distinct geographic areas - top geographies include California, Delaware, Florida.
Frequently Asked Questions
What is clinical trial NCT03915925 about?
NCT03915925 is a clinical study titled "Short-term Clinical Deterioration After Acute Pulmonary Embolism". This is a prospective, observational, multicenter cohort study to compare right ventricular dysfunction dependent and independent prognostic models for short-term serous adverse events in patients who are diagnosed with pulmonary embolism in the emergency department. Clinical endpoints are assessed ...
What is the current status of trial NCT03915925?
This trial is currently completed. The enrollment target is 935 participants. The study started on 2018-09-30. Estimated completion is 2020-11-30.
What conditions does trial NCT03915925 study?
This clinical trial studies the following conditions: Pulmonary Embolism.
Who is sponsoring clinical trial NCT03915925?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03915925 being conducted?
This trial has 6 study locations across California, Delaware, Florida, North Carolina, Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pulmonary Embolism
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Study of Mobility Outcomes in Post-Pulmonary Embolic Disease
RECRUITING · NA
-
Intervention to Improve Utilization of Extended Venous Thromboembolism Prophylaxis After Cancer Surgery
RECRUITING · NA
-
Clinical Utility of Portable Dynamic Chest X Ray (DDR) in the ICU
RECRUITING · NA
-
The PERSEVERE Study
RECRUITING · NA
-
Point-of-Care Ultrasound in Predicting Adverse Outcomes in Emergency Department Patients With Acute Pulmonary Embolism
RECRUITING
-
Supplemental Oxygen in Pulmonary Embolism (SO-PE)
RECRUITING · Early Phase 1
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.